Serum Cytokine Profiles Differentiating Hemorrhagic Fever with Renal Syndrome and Hantavirus Pulmonary Syndrome

Autores
Khaiboullina, Svetlana F; Levis, Silvana; Morzunov, Sergey P; Martynova, Ekaterina V; Anokhin, Vladimir A; Gusev, Oleg A; St. Jeor, Stephen; Lombardi, Vincent C; Rizvanov, Albert A
Año de publicación
2017
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Fil: Khaiboullina, Svetlana F. Nevada Center for Biomedical Research, Reno, NV; Estados Unidos.
Fil: Levis, Silvana. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Virales Humanas; Argentina.
Fil: Morzunov, Sergey P. Department of Pathology, University of Nevada School of Medicine, Reno, NV; Estados Unidos.
Fil: Martynova, Ekaterina V. Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan; Rusia.
Fil: Anokhin, Vladimir A. Kazan State Medical University, Kazan; Rusia.
Fil: Gusev, Oleg A. Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan; Rusia.
Fil: St. Jeor, Stephen. Department of Microbiology and Immunology, University of Nevada School of Medicine, Reno, NV; Estados Unidos.
Fil: Lombardi, Vincent C. Nevada Center for Biomedical Research, Reno, NV; Estados Unidos.
Fil: Rizvanov, Albert A. Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan; Rusia.
Hantavirus infection is an acute zoonosis that clinically manifests in two primary forms, hemorrhagic fever with renal syndrome (HFRS) and hantavirus pulmonary syndrome (HPS). HFRS is endemic in Europe and Russia, where the mild form of the disease is prevalent in the Tatarstan region. HPS is endemic in Argentina, as well as other countries of North and South American. HFRS and HPS are usually acquired via the upper respiratory tract by inhalation of virus-contaminated aerosol. Although the pathogenesis of HFRS and HPS remains largely unknown, postmortem tissue studies have identified endothelial cells as the primary target of infection. Importantly, cell damage due to virus replication, or subsequent tissue repair, has not been documented. Since no single factor has been identified that explains the complexity of HFRS or HPS pathogenesis, it has been suggested that a cytokine storm may play a crucial role in the manifestation of both diseases. In order to identify potential serological markers that distinguish HFRS and HPS, serum samples collected during early and late phases of the disease were analyzed for 48 analytes using multiplex magnetic bead-based assays. Overall, serum cytokine profiles associated with HPS revealed a more pro-inflammatory milieu as compared to HFRS. Furthermore, HPS was strictly characterized by the upregulation of cytokine levels, in contrast to HFRS where cases were distinguished by a dichotomy in serum cytokine levels. The severe form of hantavirus zoonosis, HPS, was characterized by the upregulation of a higher number of cytokines than HFRS (40 vs 21). In general, our analysis indicates that, although HPS and HFRS share many characteristic features, there are distinct cytokine profiles for these diseases. These profiles suggest a strong activation of an innate immune and inflammatory responses are associated with HPS, relative to HFRS, as well as a robust activation of Th1-type immune responses. Finally, the results of our analysis suggest that serum cytokines profiles of HPS and HFRS cases are consistent with the presence of extracellular matrix degradation, increased mononuclear leukocyte proliferation, and transendothelial migration.
Fuente
Frontiers in Immunology 2017; 8:567.
Materia
Suero
Fiebre Hemorrágica con Síndrome Renal
Síndrome Pulmonar por Hantavirus
Hantavirus
Nivel de accesibilidad
acceso abierto
Condiciones de uso
Repositorio
Sistema de Gestión del Conocimiento ANLIS MALBRÁN
Institución
Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán"
OAI Identificador
oai:sgc.anlis.gob.ar:Publications/123456789/2015

id SGCANLIS_f5920928c6a954065f1cae41de641b43
oai_identifier_str oai:sgc.anlis.gob.ar:Publications/123456789/2015
network_acronym_str SGCANLIS
repository_id_str a
network_name_str Sistema de Gestión del Conocimiento ANLIS MALBRÁN
spelling Serum Cytokine Profiles Differentiating Hemorrhagic Fever with Renal Syndrome and Hantavirus Pulmonary SyndromeKhaiboullina, Svetlana FLevis, SilvanaMorzunov, Sergey PMartynova, Ekaterina VAnokhin, Vladimir AGusev, Oleg ASt. Jeor, StephenLombardi, Vincent CRizvanov, Albert ASueroFiebre Hemorrágica con Síndrome RenalSíndrome Pulmonar por HantavirusHantavirusFil: Khaiboullina, Svetlana F. Nevada Center for Biomedical Research, Reno, NV; Estados Unidos.Fil: Levis, Silvana. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Virales Humanas; Argentina.Fil: Morzunov, Sergey P. Department of Pathology, University of Nevada School of Medicine, Reno, NV; Estados Unidos.Fil: Martynova, Ekaterina V. Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan; Rusia.Fil: Anokhin, Vladimir A. Kazan State Medical University, Kazan; Rusia.Fil: Gusev, Oleg A. Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan; Rusia.Fil: St. Jeor, Stephen. Department of Microbiology and Immunology, University of Nevada School of Medicine, Reno, NV; Estados Unidos.Fil: Lombardi, Vincent C. Nevada Center for Biomedical Research, Reno, NV; Estados Unidos.Fil: Rizvanov, Albert A. Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan; Rusia.Hantavirus infection is an acute zoonosis that clinically manifests in two primary forms, hemorrhagic fever with renal syndrome (HFRS) and hantavirus pulmonary syndrome (HPS). HFRS is endemic in Europe and Russia, where the mild form of the disease is prevalent in the Tatarstan region. HPS is endemic in Argentina, as well as other countries of North and South American. HFRS and HPS are usually acquired via the upper respiratory tract by inhalation of virus-contaminated aerosol. Although the pathogenesis of HFRS and HPS remains largely unknown, postmortem tissue studies have identified endothelial cells as the primary target of infection. Importantly, cell damage due to virus replication, or subsequent tissue repair, has not been documented. Since no single factor has been identified that explains the complexity of HFRS or HPS pathogenesis, it has been suggested that a cytokine storm may play a crucial role in the manifestation of both diseases. In order to identify potential serological markers that distinguish HFRS and HPS, serum samples collected during early and late phases of the disease were analyzed for 48 analytes using multiplex magnetic bead-based assays. Overall, serum cytokine profiles associated with HPS revealed a more pro-inflammatory milieu as compared to HFRS. Furthermore, HPS was strictly characterized by the upregulation of cytokine levels, in contrast to HFRS where cases were distinguished by a dichotomy in serum cytokine levels. The severe form of hantavirus zoonosis, HPS, was characterized by the upregulation of a higher number of cytokines than HFRS (40 vs 21). In general, our analysis indicates that, although HPS and HFRS share many characteristic features, there are distinct cytokine profiles for these diseases. These profiles suggest a strong activation of an innate immune and inflammatory responses are associated with HPS, relative to HFRS, as well as a robust activation of Th1-type immune responses. Finally, the results of our analysis suggest that serum cytokines profiles of HPS and HFRS cases are consistent with the presence of extracellular matrix degradation, increased mononuclear leukocyte proliferation, and transendothelial migration.Frontiers Media2017-05-18info:ar-repo/semantics/articuloinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdf1664-3224https://www.frontiersin.org/articles/10.3389/fimmu.2017.00567/fullhttp://sgc.anlis.gob.ar/handle/123456789/201510.3389/fimmu.2017.00567Frontiers in Immunology 2017; 8:567.reponame:Sistema de Gestión del Conocimiento ANLIS MALBRÁNinstname:Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán"instacron:ANLISFrontiers in immunologyenginfo:eu-repo/semantics/openAccess2025-09-29T14:30:35Zoai:sgc.anlis.gob.ar:Publications/123456789/2015Institucionalhttp://sgc.anlis.gob.ar/Organismo científico-tecnológicoNo correspondehttp://sgc.anlis.gob.ar/oai/biblioteca@anlis.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:a2025-09-29 14:30:35.682Sistema de Gestión del Conocimiento ANLIS MALBRÁN - Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán"false
dc.title.none.fl_str_mv Serum Cytokine Profiles Differentiating Hemorrhagic Fever with Renal Syndrome and Hantavirus Pulmonary Syndrome
title Serum Cytokine Profiles Differentiating Hemorrhagic Fever with Renal Syndrome and Hantavirus Pulmonary Syndrome
spellingShingle Serum Cytokine Profiles Differentiating Hemorrhagic Fever with Renal Syndrome and Hantavirus Pulmonary Syndrome
Khaiboullina, Svetlana F
Suero
Fiebre Hemorrágica con Síndrome Renal
Síndrome Pulmonar por Hantavirus
Hantavirus
title_short Serum Cytokine Profiles Differentiating Hemorrhagic Fever with Renal Syndrome and Hantavirus Pulmonary Syndrome
title_full Serum Cytokine Profiles Differentiating Hemorrhagic Fever with Renal Syndrome and Hantavirus Pulmonary Syndrome
title_fullStr Serum Cytokine Profiles Differentiating Hemorrhagic Fever with Renal Syndrome and Hantavirus Pulmonary Syndrome
title_full_unstemmed Serum Cytokine Profiles Differentiating Hemorrhagic Fever with Renal Syndrome and Hantavirus Pulmonary Syndrome
title_sort Serum Cytokine Profiles Differentiating Hemorrhagic Fever with Renal Syndrome and Hantavirus Pulmonary Syndrome
dc.creator.none.fl_str_mv Khaiboullina, Svetlana F
Levis, Silvana
Morzunov, Sergey P
Martynova, Ekaterina V
Anokhin, Vladimir A
Gusev, Oleg A
St. Jeor, Stephen
Lombardi, Vincent C
Rizvanov, Albert A
author Khaiboullina, Svetlana F
author_facet Khaiboullina, Svetlana F
Levis, Silvana
Morzunov, Sergey P
Martynova, Ekaterina V
Anokhin, Vladimir A
Gusev, Oleg A
St. Jeor, Stephen
Lombardi, Vincent C
Rizvanov, Albert A
author_role author
author2 Levis, Silvana
Morzunov, Sergey P
Martynova, Ekaterina V
Anokhin, Vladimir A
Gusev, Oleg A
St. Jeor, Stephen
Lombardi, Vincent C
Rizvanov, Albert A
author2_role author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Suero
Fiebre Hemorrágica con Síndrome Renal
Síndrome Pulmonar por Hantavirus
Hantavirus
topic Suero
Fiebre Hemorrágica con Síndrome Renal
Síndrome Pulmonar por Hantavirus
Hantavirus
dc.description.none.fl_txt_mv Fil: Khaiboullina, Svetlana F. Nevada Center for Biomedical Research, Reno, NV; Estados Unidos.
Fil: Levis, Silvana. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Virales Humanas; Argentina.
Fil: Morzunov, Sergey P. Department of Pathology, University of Nevada School of Medicine, Reno, NV; Estados Unidos.
Fil: Martynova, Ekaterina V. Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan; Rusia.
Fil: Anokhin, Vladimir A. Kazan State Medical University, Kazan; Rusia.
Fil: Gusev, Oleg A. Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan; Rusia.
Fil: St. Jeor, Stephen. Department of Microbiology and Immunology, University of Nevada School of Medicine, Reno, NV; Estados Unidos.
Fil: Lombardi, Vincent C. Nevada Center for Biomedical Research, Reno, NV; Estados Unidos.
Fil: Rizvanov, Albert A. Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan; Rusia.
Hantavirus infection is an acute zoonosis that clinically manifests in two primary forms, hemorrhagic fever with renal syndrome (HFRS) and hantavirus pulmonary syndrome (HPS). HFRS is endemic in Europe and Russia, where the mild form of the disease is prevalent in the Tatarstan region. HPS is endemic in Argentina, as well as other countries of North and South American. HFRS and HPS are usually acquired via the upper respiratory tract by inhalation of virus-contaminated aerosol. Although the pathogenesis of HFRS and HPS remains largely unknown, postmortem tissue studies have identified endothelial cells as the primary target of infection. Importantly, cell damage due to virus replication, or subsequent tissue repair, has not been documented. Since no single factor has been identified that explains the complexity of HFRS or HPS pathogenesis, it has been suggested that a cytokine storm may play a crucial role in the manifestation of both diseases. In order to identify potential serological markers that distinguish HFRS and HPS, serum samples collected during early and late phases of the disease were analyzed for 48 analytes using multiplex magnetic bead-based assays. Overall, serum cytokine profiles associated with HPS revealed a more pro-inflammatory milieu as compared to HFRS. Furthermore, HPS was strictly characterized by the upregulation of cytokine levels, in contrast to HFRS where cases were distinguished by a dichotomy in serum cytokine levels. The severe form of hantavirus zoonosis, HPS, was characterized by the upregulation of a higher number of cytokines than HFRS (40 vs 21). In general, our analysis indicates that, although HPS and HFRS share many characteristic features, there are distinct cytokine profiles for these diseases. These profiles suggest a strong activation of an innate immune and inflammatory responses are associated with HPS, relative to HFRS, as well as a robust activation of Th1-type immune responses. Finally, the results of our analysis suggest that serum cytokines profiles of HPS and HFRS cases are consistent with the presence of extracellular matrix degradation, increased mononuclear leukocyte proliferation, and transendothelial migration.
description Fil: Khaiboullina, Svetlana F. Nevada Center for Biomedical Research, Reno, NV; Estados Unidos.
publishDate 2017
dc.date.none.fl_str_mv 2017-05-18
dc.type.none.fl_str_mv info:ar-repo/semantics/articulo
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv 1664-3224
https://www.frontiersin.org/articles/10.3389/fimmu.2017.00567/full
http://sgc.anlis.gob.ar/handle/123456789/2015
10.3389/fimmu.2017.00567
identifier_str_mv 1664-3224
10.3389/fimmu.2017.00567
url https://www.frontiersin.org/articles/10.3389/fimmu.2017.00567/full
http://sgc.anlis.gob.ar/handle/123456789/2015
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Frontiers in immunology
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Frontiers Media
publisher.none.fl_str_mv Frontiers Media
dc.source.none.fl_str_mv Frontiers in Immunology 2017; 8:567.
reponame:Sistema de Gestión del Conocimiento ANLIS MALBRÁN
instname:Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán"
instacron:ANLIS
reponame_str Sistema de Gestión del Conocimiento ANLIS MALBRÁN
collection Sistema de Gestión del Conocimiento ANLIS MALBRÁN
instname_str Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán"
instacron_str ANLIS
institution ANLIS
repository.name.fl_str_mv Sistema de Gestión del Conocimiento ANLIS MALBRÁN - Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán"
repository.mail.fl_str_mv biblioteca@anlis.gov.ar
_version_ 1844621858422390784
score 12.559606